SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-06-008197
Filing Date
2006-04-07
Accepted
2006-04-07 13:33:20
Documents
1
Period of Report
2006-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2458
  Complete submission text file 0001179110-06-008197.txt   4359
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452
Business Address 781-398-0700
Mayer Gregg Thomas (Reporting) CIK: 0001358627 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 06747287